VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Azadirachta Indica
Preclinical
Small molecule
R
Roswell Park Cancer Institute
1
Indications
4
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Chlorhexidine
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Chlorhexidine
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Acne Vulgaris
1 trial
Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris
Completed
·
M
Miglani, Anjali
·
Phase 1
·
NCT01321645
·
31 enrolled
Surgical
1 trial
Azadirachta Indica (Neem) Extract as an Adjunct to Non-Surgical Periodontal Management
Completed
·
—
·
Phase 2
·
NCT06050174
·
32 enrolled
Chronic Lymphocytic Leukemia
1 trial
Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia
Withdrawn
·
R
Roswell Park Cancer Institute
·
Phase 1
·
NCT01251250
Chlorhexidine
1 trial
Evaluation of Bleeding on Brushing Using Neem Extract Mouthwash Versus Chlorhexidine Mouthwash
Unknown status
·
—
·
N/A
·
NCT03166163
·
86 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
4 trial records for Azadirachta Indica. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Azadirachta Indica compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Azadirachta Indica. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Roswell Park Cancer Institute company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
R
Roswell Park Cancer Institute
Related News